Answers are grounded in this paper and cite their sources.
This review collates and analyses recent work done on dual action approaches to tackling the mounting health problem of resistance by human pathogenic bacteria to antibacterial agents. In particular the areas reviewed include the use of two drugs in combination, dual action prodrugs, and dual action drugs (or hybrid drugs)
No takes yet. Share an insight, caveat, or question.
Bremner et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: